RAAS inhibitors do not increase the risk of COVID-19
Irene Fernández-Ruíz
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Angiotensin Receptor BlockersMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseInternal medicineAngiotensin-converting enzymeRenin–angiotensin systemCoronavirusVirologyInfectious disease (medical specialty)Blood pressureOutbreakCOVID-19 Clinical Research StudiesVitamin C and Antioxidants ResearchSARS-CoV-2 and COVID-19 Research